Mirum Pharmaceuticals (NasdaqGM:MIRM) Q3 2025 Earnings Call November 04, 2025 04:30 PM ET Company ParticipantsAndrew McKibben - SVP of Strategic Finance and Investor RelationsJon Wolleben - Managing DirectorJoshua Schimmer - Managing DirectorPeter Radovich - President and COORyan Deschner - Vice President and Equity Research- BiotechChris Peetz - CEOJoanne Quan - CMOGavin Clark-Gardner - Managing Director and Biotechnology Equity ResearchEric Bjerkholt - CFOConference Call ParticipantsNone - Analyst 2None - ...